End-of-day quote
Shanghai S.E.
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
9.34
CNY
|
-.--%
|
|
+1.74%
|
-27.20%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,712
|
2,400
|
2,113
|
1,895
|
1,358
|
-
|
-
|
Enterprise Value (EV)
1 |
2,712
|
2,400
|
2,113
|
1,895
|
1,358
|
1,358
|
1,358
|
P/E ratio
|
-
|
36.4
x
|
18.3
x
|
18.9
x
|
19.5
x
|
15.8
x
|
13.5
x
|
Yield
|
-
|
-
|
-
|
2.73%
|
1.71%
|
2.14%
|
2.46%
|
Capitalization / Revenue
|
7.21
x
|
-
|
-
|
3.29
x
|
3.45
x
|
2.92
x
|
2.41
x
|
EV / Revenue
|
7.21
x
|
-
|
-
|
3.29
x
|
3.45
x
|
2.92
x
|
2.41
x
|
EV / EBITDA
|
-
|
-
|
-
|
10.4
x
|
9.7
x
|
7.3
x
|
5.07
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.52
x
|
-
|
-
|
1.51
x
|
1.08
x
|
1.03
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
147,219
|
147,219
|
147,219
|
147,698
|
145,375
|
-
|
-
|
Reference price
2 |
18.42
|
16.31
|
14.35
|
12.83
|
9.340
|
9.340
|
9.340
|
Announcement Date
|
2/24/21
|
2/25/22
|
3/30/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
376.1
|
-
|
-
|
576.1
|
394
|
465
|
564
|
EBITDA
1 |
-
|
-
|
-
|
182
|
140
|
186
|
268
|
EBIT
1 |
76
|
-
|
-
|
119.6
|
78
|
95
|
112
|
Operating Margin
|
20.21%
|
-
|
-
|
20.75%
|
19.8%
|
20.43%
|
19.86%
|
Earnings before Tax (EBT)
1 |
75.67
|
-
|
-
|
107.2
|
79
|
96
|
113
|
Net income
1 |
67.24
|
65.9
|
115.3
|
100
|
71
|
87
|
102
|
Net margin
|
17.88%
|
-
|
-
|
17.37%
|
18.02%
|
18.71%
|
18.09%
|
EPS
2 |
-
|
0.4483
|
0.7862
|
0.6800
|
0.4800
|
0.5900
|
0.6900
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.3500
|
0.1600
|
0.2000
|
0.2300
|
Announcement Date
|
2/24/21
|
2/25/22
|
3/30/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.6%
|
-
|
-
|
8.02%
|
5.53%
|
6.45%
|
7.18%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
6.5%
|
4.83%
|
5.56%
|
6.05%
|
Assets
1 |
-
|
-
|
-
|
1,539
|
1,470
|
1,565
|
1,686
|
Book Value Per Share
2 |
7.330
|
-
|
-
|
8.490
|
8.670
|
9.100
|
9.590
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-0.0800
|
1.870
|
1.120
|
1.620
|
Capex
1 |
-
|
-
|
-
|
138
|
93
|
104
|
76
|
Capex / Sales
|
-
|
-
|
-
|
23.98%
|
23.6%
|
22.37%
|
13.48%
|
Announcement Date
|
2/24/21
|
2/25/22
|
3/30/23
|
2/26/24
|
-
|
-
|
-
|
Last Close Price
9.34
CNY Average target price
11.52
CNY Spread / Average Target +23.34% Consensus |
1st Jan change
|
Capi.
|
---|
| -27.20% | 187M | | +12.75% | 8.87B | | +49.49% | 2.57B | | -14.78% | 1.01B | | +23.42% | 874M | | -7.77% | 754M | | +24.67% | 721M | | +16.43% | 696M | | -17.24% | 583M | | -11.94% | 533M |
Purification & Treatment Equipment
|